Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Distribution of TNF-genotypes in RA patients did not differ from that in controls.
|
17763852 |
2007 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This study was aimed to investigate the association of the single nucleotide polymorphism of tumor necrosis factor receptor associated factor 6 (TRAF6), rs540386, with low bone mineral density (BMD) among patients with rheumatoid arthritis (RA).
|
30506403 |
2019 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We describe here an Nco I restriction fragment length polymorphism of tumor necrosis factor carried by the 8.1 (HLA-A1,B8,BfS,C4AQ0,C4B1,DR3) and the 44.1 (HLA-B44,BfS,C4A3,C4BQ0,DR4) ancestral haplotypes associated with complications of rheumatoid arthritis.
|
2573586 |
1989 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These results confirm that the TNF locus exerts a primary influence on both susceptibility to and the severity of RA.
|
17631742 |
2007 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis.
|
18634161 |
2008 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Genetic variants located close to 2 genes codifying for members of the tumor necrosis factor receptor superfamily (TNFRSF), TNFRSF14 and TNFRSF6B, have recently been associated with rheumatoid arthritis (RA) and with inflammatory bowel disease susceptibility, respectively.
|
20187130 |
2010 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?
|
16446172 |
2006 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Replication of the tumor necrosis factor receptor-associated factor 1/complement component 5 region as a susceptibility locus for rheumatoid arthritis in a European family-based study.
|
18759306 |
2008 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To assess the role of polymorphisms of the tumour necrosis factor (TNF) receptors, TNF-RI (p55) and TNF-RII (p75) in the susceptibility to and severity of rheumatoid arthritis (RA) in Dutch patients.
|
12730509 |
2003 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This metaanalysis demonstrates that the TNF-alpha -308 A/G polymorphism may represent a significant risk factor for RA in Latin Americans, but not in Europeans.
|
17143972 |
2007 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To provide real world evidence about the reasons why Australian rheumatologists cease biologic (b) and targeted synthetic (ts) disease-modifying anti-rheumatic drugs (DMARDs) when treating rheumatoid arthritis (RA) patients and to assess primary failure rate for first-line treatment and the persistence on second-line treatments in patients who stopped first-line tumor necrosis factor inhibitors (TNFi).
|
31787605 |
2019 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Combination treatments for patients with rheumatoid arthritis (RA) with an inadequate response to methotrexate (MTX) alone include the addition of a tumor necrosis factor inhibitor (TNFi) or the addition of sulfasalazine (SSZ) and hydroxychloroquine to MTX (triple therapy).
|
30221485 |
2019 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.
|
19411391 |
2009 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To date, many studies explored the associations between tumor necrosis factor alpha inducible protein 3 (TNFAIP3) gene rs6920220, rs2230926, and rs5029937 polymorphisms and the risk of rheumatoid arthritis (RA), but with contradictory results.
|
28199970 |
2017 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We aimed to evaluate the risks of HZ in tumor necrosis factor inhibitor (TNFI) and non-TNFI users with rheumatoid arthritis (RA) over 3 years in Japan.
|
29667330 |
2018 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To define the safety and efficacy of TNF inhibitors (TNFi) in RA patients with comorbidities.
|
30289537 |
2018 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans.
|
15725578 |
2005 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This meta-analysis showed that the TNF-α -308 A/G polymorphism may represent a significant risk factor for RA in Latin Americans but not in the European, Arab, or Asian populations.
|
24306269 |
2014 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To compare the risk for major adverse cardiovascular events (MACE) in RA patients treated with tocilizumab versus the tumor necrosis factor inhibitor etanercept.
|
31469238 |
2020 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that the susceptible gene to RA is more closely linked to the HLA-DRB1 locus than to the TNF-alpha locus.
|
10488748 |
1999 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The carriage of the A allele for TNF-alpha of -308 SNP in 4 of the 5 RA patients, and the high prevalence (68.0%) of TNF A allele carriers in this family confirms the important role of this candidate gene in the pathomechanism of RA, and might be of prognostic value for future clinical observations.
|
15571066 |
2004 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
TNF-α rs1800629 A/G, NLRP1 rs878329 C/G and NLRP1 rs6502867 C/T polymorphisms were not associated with risk of RA or AS.
|
24065540 |
2013 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The results of this study demonstrate the association of the TNF-α-308 G allele and GG homozygous genotype with susceptibility to RA and the A allele with the presence of erosion in the Egyptian patients.
|
21806780 |
2011 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Our results show that TNFA rs1800629 gene polymorphism is associated with predisposition to CV complications in patients with RA.
|
21420089 |
2011 |
Rheumatoid Arthritis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The PTPRC rs10919563 A allele shows a poor response to anti-TNF therapy, and the FCGR2A HH + HR genotype shows a poor response to adalimumab for RA.
|
27074847 |
2016 |